Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8901105
SERIAL NO

14010166

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In part, the present disclosure is directed to prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide compounds with significant solubility and bioavailability profiles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEBIOPHARM INTERNATIONAL SA1006 LAUSANNE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Colucci, John Kirkland, CA 29 134
Gareau, Yves Notre-Dame de l'ile-Perrot, CA 24 264
Hafkin, Barry Austin, US 4 15
Marfat, Anthony Mystic, US 79 789
Partridge, John J Chapel Hill, US 51 493
Therien, Michel Laval, CA 50 1525
Zaghdane, Helmi Pincourt, CA 8 69
Zamboni, Robert Beaconsfield, CA 53 319

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 2, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00